Trexquant Investment’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$700K Buy
+86,067
New +$553K ﹤0.01% 1581
2026
Q2
– Sell
-33,394
Closed -$100K – 2278
2026
Q1
$100K Sell
33,394
-22,215
-40% -$85.9K ﹤0.01% 1703
2025
Q4
$338K Buy
55,609
+44,504
+401% +$405K ﹤0.01% 1424
2025
Q3
$122K Buy
+11,105
New +$98.4K ﹤0.01% 1534

Other funds holding XGN

Trexquant Investment's XGN Position: Q3 2026 in Review

Trexquant Investment opened a new position in Exagen (XGN) in Q3 2026: 86,067 shares worth $700K. The stake represents ﹤0.01% of the portfolio and ranks #1581 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in XGN as recently as Q1 2026.

Trexquant Investment first reported a position in XGN in Q3 2025 and has held it in 4 quarters since. 78 funds tracked by Wall St. Rank hold XGN as of Q3 2026.

  • Trexquant Investment held 86,067 shares of Exagen worth $700K as of Q3 2026.
  • Exagen was a new Trexquant Investment position in Q3 2026.
  • Exagen made up ﹤0.01% of Trexquant Investment's portfolio in Q3 2026, its #1581 holding.
  • Trexquant Investment first reported a position in Exagen in Q3 2025 and has held it in 4 quarters since.
  • 78 funds tracked by Wall St. Rank held Exagen as of Q3 2026.

Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.